Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
New York, USA, May 11, 2026 (GLOBE NEWSWIRE) -- Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034 | DelveInsight The personalized medicine market is...
-
New York, USA, May 11, 2026 (GLOBE NEWSWIRE) -- Presbyopia Market to Witness Accelerated Growth at a CAGR of 4.9% During the Forecast Period (2026–2036) Supported by Expanding Treatment Landscape |...
-
New York, USA, May 07, 2026 (GLOBE NEWSWIRE) -- Global Ambulance Service Market is Set to Cross USD 100 Billion by 2034 | DelveInsight The ambulance services market is largely fueled by the...
-
New York, USA, May 07, 2026 (GLOBE NEWSWIRE) -- PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The PARP...
-
New York, USA, May 06, 2026 (GLOBE NEWSWIRE) -- Global Healthcare Analytics Market is Predicted to Cross the USD 380 Billion Mark by 2034 | DelveInsight The healthcare analytics market is largely...
-
New York, USA, May 06, 2026 (GLOBE NEWSWIRE) -- Global DNA Microarray Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2034 | DelveInsight The DNA microarray market is...
-
New York, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations |...
-
New York, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight The hemophilia clinical...
-
New York, USA, May 04, 2026 (GLOBE NEWSWIRE) -- Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsight The plasmid DNA...
-
New York, USA, May 04, 2026 (GLOBE NEWSWIRE) -- Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight The...